Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000079475 | SCV000111354 | benign | not specified | 2013-05-09 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000079475 | SCV000306686 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000079475 | SCV000518282 | benign | not specified | 2016-01-07 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV002311575 | SCV000845844 | benign | Inborn genetic diseases | 2016-01-08 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV001511466 | SCV001718715 | benign | Episodic ataxia type 2; Developmental and epileptic encephalopathy, 42 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001554425 | SCV001775670 | benign | Developmental and epileptic encephalopathy, 42 | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001554426 | SCV001775671 | benign | Episodic ataxia type 2 | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001554427 | SCV001775672 | benign | Migraine, familial hemiplegic, 1 | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001554428 | SCV001775673 | benign | Spinocerebellar ataxia type 6 | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000079475 | SCV000150462 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. | |
Diagnostic Laboratory, |
RCV000079475 | SCV001744410 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000079475 | SCV001955457 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000079475 | SCV001973520 | benign | not specified | no assertion criteria provided | clinical testing |